EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Distinct Neurodegenerative Pathways in Two NBIA Subtypes: Inflammatory Activation in C19orf12 but Not in PANK2 Mutation Carriers

Marta Skowrońska iD, Agnieszka Cudna iD, Barbara Pakuła iD, Magdalena Lebiedzińska-Arciszewska iD, Justyna Janikiewicz iD, Aneta M Dobosz iD, Patrycja Jakubek-Olszewska iD, Agata Wydrych iD, Maciej Cwyl, Agnieszka Dobrzyń, Mariusz R Więckowski iD, Iwona Kurkowska-Jastrzębska iD

Cells · 2025

DOI: 10.3390/cells14221801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Marta Skowrońska und 11 weiteren Autor:innen. Beteiligte Einrichtung: 2nd Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland. Hauptthemen laut MEDLINE: Mutation, Inflammation, Mitochondrial Proteins, Phosphotransferases (Alcohol Group Acceptor). Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Education and Science of Poland, Ministry of Education and Science of Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biomarker analysis in neurodegeneration with brain iron accumulation (NBIA) can offer valuable insights into the disease’s pathology and natural history.

Methods

Twenty-five patients with C19orf12 mutations causing mitochondrial membrane protein-associated neurodegeneration (MPAN), 12 patients with PANK2 mutations causing pantothenate kinase-associated neurodegeneration (PKAN), and 30 age- and gender-matched controls were studied. Serum levels of MMP-9, S100B, ICAM-1, E- and P-selectins, total α-synuclein, neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), Tau, ubiquitin-C-terminal hydrolase-L1 (UCH-L1), and brain-derived neurotrophic factor (BDNF) were measured. Clinical status was evaluated with dedicated rating scales.

Results

Compared to the control group, MPAN patients had significantly higher serum levels of nearly all biomarkers, except BDNF. NfL, GFAP, and UCH-L1, were elevated by 5, 2, and 3.5 times, respectively. PKAN patients showed no significant differences in GFAP, UCH-L1, and S100B levels compared to controls. However, NfL and Tau levels were increased by 3 and 1.8 times, respectively. A correlation was observed between disease severity and levels of NfL, Tau, and UCH-L1 in MPAN, and GFAP, Tau, and UCH-L1 in PKAN.

Conclusions

Patients with MPAN and PKAN showed increased levels of neurodegeneration biomarkers. Elevated inflammation and blood–brain barrier dysfunction biomarkers were specific to MPAN patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationInflammationMitochondrial ProteinsPhosphotransferases (Alcohol Group Acceptor)Neuroaxonal DystrophiesPantothenate Kinase-Associated NeurodegenerationHumansFemaleMaleMiddle AgedBiomarkersAdultHeterozygoteYoung AdultAgedCase-Control StudiesIron Metabolism Disorders

Stichwörter der Autor:innen

MPANPKANbiomarkersneurodegeneration with brain iron accumulation

Substanzen

BiomarkersC19orf12 protein, humanMitochondrial ProteinsPhosphotransferases (Alcohol Group Acceptor)

Autor:innen und Institutionen

  • 2nd Department of Neurology, Institute of Psychiatry and Neurology, 02-957 Warsaw, Poland.
  • Laboratory of Mitochondrial Biology and Metabolism, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland.
  • Laboratory of Cell Signaling and Metabolic Disorders, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland.
  • Association NBIA Polska, 00-453 Warsaw, Poland.

ORCID-Profile: Marta Skowrońska, Agnieszka Cudna, Barbara Pakuła, Magdalena Lebiedzińska-Arciszewska, Justyna Janikiewicz, Aneta M Dobosz, Patrycja Jakubek-Olszewska, Agata Wydrych, Mariusz R Więckowski, Iwona Kurkowska-Jastrzębska

Förderung

  • the Ministry of Education and Science of Poland
  • Ministry of Education and Science of Poland

Zitieren

APA

Skowrońska, M., Cudna, A., Pakuła, B., Lebiedzińska-Arciszewska, M., Janikiewicz, J., Dobosz, A. M., Jakubek-Olszewska, P., Wydrych, A., Cwyl, M., Dobrzyń, A., Więckowski, M. R., & Kurkowska-Jastrzębska, I. (2025). Distinct Neurodegenerative Pathways in Two NBIA Subtypes: Inflammatory Activation in C19orf12 but Not in PANK2 Mutation Carriers. Cells. https://doi.org/10.3390/cells14221801

Vancouver

Skowrońska M, Cudna A, Pakuła B, Lebiedzińska-Arciszewska M, Janikiewicz J, Dobosz AM, et al. Distinct Neurodegenerative Pathways in Two NBIA Subtypes: Inflammatory Activation in C19orf12 but Not in PANK2 Mutation Carriers. Cells. 2025. doi:10.3390/cells14221801

BibTeX
@article{Skowroska2025,
  author = {Skowrońska, Marta and Cudna, Agnieszka and Pakuła, Barbara and Lebiedzińska-Arciszewska, Magdalena and Janikiewicz, Justyna and Dobosz, Aneta M and Jakubek-Olszewska, Patrycja and Wydrych, Agata and Cwyl, Maciej and Dobrzyń, Agnieszka and Więckowski, Mariusz R and Kurkowska-Jastrzębska, Iwona},
  title = {Distinct Neurodegenerative Pathways in Two NBIA Subtypes: Inflammatory Activation in C19orf12 but Not in PANK2 Mutation Carriers},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14221801}
}
Kostenlos starten →